부산대학교 도서관

Soeung M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Yan X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zanca C; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Qian J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.; Karki M; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.; Duan F; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.; Khan H; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhang L; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Peng DH; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Williams M; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; He R; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.; Chen Z; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Perelli L; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Cancer Biology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.; Chen J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.; Tidwell RS; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chauhan PK; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.; Le CN; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lam TNA; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bhattacharya N; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Shah R; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences (GSBS), Houston, TX, USA.; Ho IL; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gay JP; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Carrillo CC; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Feng N; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Le K; Institute for Applied Cancer Science (IACS), Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Gao G; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Perry TL; Institute for Applied Cancer Science (IACS), Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Mseeh F; Institute for Applied Cancer Science (IACS), Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Jiang Y; Institute for Applied Cancer Science (IACS), Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Xu QA; Institute for Applied Cancer Science (IACS), Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Zacharias NM; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Sheth RA; Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bathala TK; Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rao P; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Daw NC; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tripathi DN; Center for Precision Environmental Health, Baylor college of Medicine, Houston, TX, USA.; Walker CL; Center for Precision Environmental Health, Baylor college of Medicine, Houston, TX, USA.; Mohammad MM; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Han G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chu Y; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang R; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Dang M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Dai E; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Peng F; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Liu Y; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jadhav A; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lang W; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Arrechedera CA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Clemente LC; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Parra ER; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lu H; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Haymaker CL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Futreal A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Viale A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Soth MJ; Institute for Applied Cancer Science (IACS), Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Jones P; Institute for Applied Cancer Science (IACS), Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Marszalek JR; Institute for Applied Cancer Science (IACS), Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Heffernan T; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Draetta GF; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tannir NM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gao J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jgao1@mdanderson.org.; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. jgao1@mdanderson.org.; Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. lwang22@mdanderson.org.; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences (GSBS), Houston, TX, USA. lwang22@mdanderson.org.; The James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. lwang22@mdanderson.org.; Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. lwang22@mdanderson.org.; Genovese G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ggenovese@mdanderson.org.; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ggenovese@mdanderson.org.; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ggenovese@mdanderson.org.; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. ggenovese@mdanderson.org.; Msaouel P; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. pmsaouel@mdanderson.org.; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. pmsaouel@mdanderson.org.; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences (GSBS), Houston, TX, USA. pmsaouel@mdanderson.org.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. pmsaouel@mdanderson.org.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Baran, Natalia ; Lodi, Alessia ; Dhungana, Yogesh ; Sweeney, Shannon RENEE ; Renu, Pandey ; Herbrich, Shelley ; Hoff, Fieke W ; Skwarska, Anna ; Kaplan, Mecit ; Kuruvilla, Vinitha Mary ; Cavazos, Antonio ; Warmoes, Marc ; Rojas-Sutterlin, Shanti ; Haman, Andre ; Veiga, Diogo Troggian ; Furudate, Ken ; Ma, Helen ; Harutyunyan, Karine ; Yang, Wentao ; Gagea, Mihai ; Du, Di ; Daher, May ; Garcia, Luciana Melo ; Piya, Sujan ; Ruvolo, Vivian ; Shanmugavelandy, Sriram ; Feng, Ningping ; Gay, Jason P ; Havranek, Ondrej ; Henderson, Jared ; Tomczak, Katarzyna ; Kaminski, Marcin ; Herranz, Daniel ; Ferrando, Adolfo ; Jabbour, Elias ; Di Francesco, Maria E ; Teachey, David T. ; Horton, Terzah M. ; Rezvani, Katayoun ; Yang, Jun J. ; Kornblau, Steven M. ; Davis, Eric ; Takahashi, Koichi ; Andreeff, Michael ; Marszalek, Joseph R ; Lorenzi, Philip ; Yu, Jiyang ; Tiziani, Stefano ; Hoang, Trang ; Konopleva, Marina

In Blood 5 November 2020 136 Supplement 1:18-20

Baran, Natalia ; Han, Lina ; Stuani, Lucille ; Cavazos, Antonio ; Cooper, Laurie ; Ramage, Cassandra L. ; Kuruvilla, Vinitha MARY ; Zhang, Qi ; Sabtier, Marie ; Boet, Emeline ; Gay, Jason P ; Feng, Ninping ; Battula, Venkata Lokesh ; Chu-Van, Emeline ; Castelli, Florence ; Carroll, Martin ; Konoplev, Sergej Naumovich ; Thakral, Beenu ; Daver, Naval ; Marszalek, Joseph R ; Ge, Yubin ; Andreeff, Michael ; Sarry, Jean-Emmanuel ; Konopleva, Marina Y.

In Blood 2 November 2023 142 Supplement 1:2952-2952

Han, Lina ; Cavazos, Antonio ; Baran, Natalia ; Zhang, Qi ; Kuruvilla, Vinitha Mary ; Gay, Jason P ; Feng, Ningping ; Battula, Venkata Lokesh ; Kantarjian, Hagop M. ; Daver, Naval G. ; Marszalek, Joseph R ; Andreeff, Michael ; Konopleva, Marina Y

In Blood 13 November 2019 134 Supplement 1:5161-5161

Baran, Natalia ; Lodi, Alessia ; Sweeney, Shannon Renee ; Kuruvilla, Vinitha Mary ; Cavazos, Antonio ; Herranz, Daniel ; Skwarska, Anna ; Warmoes, Marc ; Davis, Eric ; Harutyunyan, Karine ; Feng, Ningping ; Gay, Jason P ; Kaminski, Marcin ; Konoplev, Sergej ; Jabbour, Elias ; Ferrando, Adolfo A. ; Di Francesco, Maria E ; Lorenzi, Philip ; Marszalek, Joseph R ; Tiziani, Stefano ; Konopleva, Marina Y ; Renu, Pandey

In Blood 13 November 2019 134 Supplement 1:806-806

Baran, Natalia ; Lodi, Alessia ; Sweeney, Shannon Renee ; Renu, Pandey ; Kuruvilla, Vinitha Mary ; Cavazos, Antonio ; Herranz, Daniel ; Skwarska, Anna ; Warmoes, Marc ; Davis, R. Eric ; Harutyunyan, Karine ; Feng, Ningping ; Gay, Jason P ; Konoplev, Sergej Naumovich ; Kaminski, Marcin ; Kovacs, Jeffrey J ; Du, Di ; Jabbour, Elias J. ; Ferrando, Adolfo A. ; Di Francesco, Maria E ; Lorenzi, Philip L ; Marszalek, Joseph R ; Tiziani, Stefano ; Konopleva, Marina Y.

In Blood 29 November 2018 132 Supplement 1:4020-4020

Han, Lina ; Cavazos, Antonio ; Baran, Natalia ; Zhang, Qi ; Kuruvilla, Vinitha Mary ; Gay, Jason P ; Feng, Ningping ; Battula, Venkata Lokesh ; Andreeff, Michael ; Kantarjian, Hagop M. ; Daver, Naval ; Marszalek, Joseph R ; Konopleva, Marina

In Blood 8 December 2017 130 Supplement 1:2623-2623

Baran, Natalia ; Han, Lina ; Sweeney, Shannon Renee ; Lodi, Alessia ; Herbrich, Shelley ; Cavazos, Antonio ; Ma, Helen ; Gay, Jason P ; Feng, Ningping ; Chen, Hsiang-Chun ; Kaminski, Marcin ; Dunner, Kenneth, Jr. ; Tang, Guilin ; Alatrash, Gheath ; Molina, Jennifer ; Guzman, Monica L. ; Ning, Jing ; Tiziani, Stefano ; Marszalek, Joseph R ; Konopleva, Marina

In Blood 8 December 2017 130 Supplement 1:1350-1350

Murphy, Kristen L; Kittrell, Frances S; Gay, Jason P; Jäger, Richard; Medina, Daniel; Rosen, Jeffrey M

Oncogene. 11/11/99, Vol. 18 Issue 47, p6597. 8p.

Chen Z; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ZChen13@mdanderson.org.; Ho IL; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Soeung M; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Yen EY; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Liu J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Yan L; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rose JL; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Translational Research to AdvanCe Therapeutics and Innovation in ONcology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Srinivasan S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Translational Research to AdvanCe Therapeutics and Innovation in ONcology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jiang S; Translational Research to AdvanCe Therapeutics and Innovation in ONcology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Edward Chang Q; The Oncology Research for Biologics and Immunotherapy Translation (ORBIT), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Feng N; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gay JP; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang Q; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lorenzi PL; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Veillon LJ; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wei B; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Weinstein JN; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Deem AK; Translational Research to AdvanCe Therapeutics and Innovation in ONcology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gao S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Genovese G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Viale A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Yao W; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, University of Texas, Houston, TX, USA.; Lyssiotis CA; Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, 48109, USA.; University of Michigan Rogel Cancer Center, University of Michigan, Ann Arbor, MI, 48109, USA.; Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, 48109, USA.; Marszalek JR; Translational Research to AdvanCe Therapeutics and Innovation in ONcology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Draetta GF; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. GDraetta@mdanderson.org.; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. GDraetta@mdanderson.org.; Ying H; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. hying@mdanderson.org.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Delahoussaye AM; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Abi Jaoude J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Green M; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Fujimoto TN; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Molkentine J; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Garcia Garcia CJ; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Gay JP; Translational Research To AdvanCe Therapeutics and Innovation in ONcology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Feng N; Translational Research To AdvanCe Therapeutics and Innovation in ONcology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Marszalek J; Translational Research To AdvanCe Therapeutics and Innovation in ONcology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Fowlkes N; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Taniguchi CM; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. ctaniguchi@mdanderson.org.

Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Giuliani V; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. VGiuliani@mdanderson.org.; Miller MA; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Liu CY; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hartono SR; Department of Molecular and Cellular Biology and Genome Center, University of California, Davis, CA, USA.; Class CA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pharmaceutical Sciences, Butler University, Indianapolis, IN, USA.; Bristow CA; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Suzuki E; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Sanz LA; Department of Molecular and Cellular Biology and Genome Center, University of California, Davis, CA, USA.; Gao G; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gay JP; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Feng N; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rose JL; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tomihara H; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Surgery, Kindai University Nara Hospital, Nara, JP, USA.; Daniele JR; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Peoples MD; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bardenhagen JP; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Geck Do MK; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chang QE; ORBIT, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Vangamudi B; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Exo Therapeutics, Cambridge, MA, USA.; Vellano C; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ying H; Department of Cellular and Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Deem AK; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Do KA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Genovese G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Marszalek JR; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kovacs JJ; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kim M; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fleming JB; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Division of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.; Guccione E; Department of Oncological Sciences and Pharmacological Sciences at Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Viale A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Maitra A; Sheikh Ahmed Bin Zayed Al Nahyan Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Emilia Di Francesco M; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Yap TA; Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Jones P; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Draetta G; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Carugo A; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chedin F; Department of Molecular and Cellular Biology and Genome Center, University of California, Davis, CA, USA.; Heffernan TP; Traction, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. TPHeffernan@mdanderson.org.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Ginger, Melanie R; Gonzalez-Rimbau, Maria F; Gay, Jason P; Rosen, Jeffrey M

Molecular Endocrinology. Nov 01, 2001 15(11):1993-2009

Yap TA; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. TYap@mdanderson.org.; Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA. TYap@mdanderson.org.; Daver N; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Mahendra M; Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhang J; Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kamiya-Matsuoka C; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Meric-Bernstam F; Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kantarjian HM; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ravandi F; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Collins ME; Department of Nutritional Sciences, College of Natural Sciences, The University of Texas at Austin, Austin, TX, USA.; Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, TX, USA.; Francesco MED; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Dumbrava EE; Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fu S; Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gao S; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gay JP; Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gera S; Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Han J; Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hong DS; Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jabbour EJ; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ju Z; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Karp DD; Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lodi A; Department of Nutritional Sciences, College of Natural Sciences, The University of Texas at Austin, Austin, TX, USA.; Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, TX, USA.; Molina JR; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Baran N; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Naing A; Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ohanian M; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pant S; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pemmaraju N; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bose P; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Piha-Paul SA; Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rodon J; Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Salguero C; Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Sasaki K; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Singh AK; Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Subbiah V; Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tsimberidou AM; Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Xu QA; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Yilmaz M; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhang Q; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Li Y; Department of Biostatistics and Data Science, The University of Texas Health Science Center at Houston, Houston, TX, USA.; Bristow CA; Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bhattacharjee MB; Department of Pathology and Laboratory Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.; Tiziani S; Department of Nutritional Sciences, College of Natural Sciences, The University of Texas at Austin, Austin, TX, USA.; Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, TX, USA.; Department of Oncology, Dell Medical School, Livestrong Cancer Institutes, The University of Texas at Austin, Austin, TX, USA.; Heffernan TP; Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Vellano CP; Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jones P; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. pjones3@mdanderson.org.; Heijnen CJ; Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Psychological Sciences, Rice University, Houston, TX, USA.; Kavelaars A; Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Marszalek JR; Translational Research to AdvanCe Therapeutics and Innovation in ONcology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jrmarszalek@mdanderson.org.; Konopleva M; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mkonople@mdanderson.org.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Powell DR; Lexicon Pharmaceuticals, Inc. , The Woodlands, TX , USA.; Gay JP; Lexicon Pharmaceuticals, Inc. , The Woodlands, TX , USA.; Wilganowski N; Lexicon Pharmaceuticals, Inc. , The Woodlands, TX , USA.; Doree D; Lexicon Pharmaceuticals, Inc. , The Woodlands, TX , USA.; Savelieva KV; Lexicon Pharmaceuticals, Inc. , The Woodlands, TX , USA.; Lanthorn TH; Lexicon Pharmaceuticals, Inc. , The Woodlands, TX , USA.; Read R; Lexicon Pharmaceuticals, Inc. , The Woodlands, TX , USA.; Vogel P; Lexicon Pharmaceuticals, Inc. , The Woodlands, TX , USA.; Hansen GM; Lexicon Pharmaceuticals, Inc. , The Woodlands, TX , USA.; Brommage R; Lexicon Pharmaceuticals, Inc. , The Woodlands, TX , USA.; Ding ZM; Lexicon Pharmaceuticals, Inc. , The Woodlands, TX , USA.; Desai U; Lexicon Pharmaceuticals, Inc. , The Woodlands, TX , USA.; Zambrowicz B; Lexicon Pharmaceuticals, Inc. , The Woodlands, TX , USA.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: PubMed not MEDLINE

Soth MJ; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Le K; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Di Francesco ME; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Hamilton MM; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Liu G; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Burke JP; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Carroll CL; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Kovacs JJ; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Bardenhagen JP; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Bristow CA; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Cardozo M; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Czako B; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; de Stanchina E; Antitumor Assessment Core Facility-Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.; Feng N; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Garvey JR; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Gay JP; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Do MKG; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Greer J; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Han M; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Harris A; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Herrera Z; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Huang S; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Giuliani V; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Jiang Y; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Johnson SB; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Johnson TA; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Kang Z; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Leonard PG; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Liu Z; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; McAfoos T; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Miller M; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Morlacchi P; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Mullinax RA; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Palmer WS; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Pang J; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Rogers N; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Rudin CM; Drunkenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York New York 10065, United States.; Shepard HE; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Spencer ND; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Theroff J; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Wu Q; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Xu A; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Yau JA; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Draetta G; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Toniatti C; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Heffernan TP; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.; Jones P; Institute for Applied Cancer Science (IACS), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.

Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

Powell DR; Metabolism Research, Lexicon Pharmaceuticals, Inc., The Woodlands, TX, USA.; Gay JP; Metabolism Research, Lexicon Pharmaceuticals, Inc., The Woodlands, TX, USA.; Smith M; Metabolism Research, Lexicon Pharmaceuticals, Inc., The Woodlands, TX, USA.; Wilganowski N; Metabolism Research, Lexicon Pharmaceuticals, Inc., The Woodlands, TX, USA.; Harris A; Metabolism Research, Lexicon Pharmaceuticals, Inc., The Woodlands, TX, USA.; Holland A; Metabolism Research, Lexicon Pharmaceuticals, Inc., The Woodlands, TX, USA.; Reyes M; Metabolism Research, Lexicon Pharmaceuticals, Inc., The Woodlands, TX, USA.; Kirkham L; Metabolism Research, Lexicon Pharmaceuticals, Inc., The Woodlands, TX, USA.; Kirkpatrick LL; Metabolism Research, Lexicon Pharmaceuticals, Inc., The Woodlands, TX, USA.; Zambrowicz B; Metabolism Research, Lexicon Pharmaceuticals, Inc., The Woodlands, TX, USA.; Hansen G; Metabolism Research, Lexicon Pharmaceuticals, Inc., The Woodlands, TX, USA.; Platt KA; Metabolism Research, Lexicon Pharmaceuticals, Inc., The Woodlands, TX, USA.; van Sligtenhorst I; Metabolism Research, Lexicon Pharmaceuticals, Inc., The Woodlands, TX, USA.; Ding ZM; Metabolism Research, Lexicon Pharmaceuticals, Inc., The Woodlands, TX, USA.; Desai U; Metabolism Research, Lexicon Pharmaceuticals, Inc., The Woodlands, TX, USA.

Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101515585 Publication Model: eCollection Cited Medium: Print ISSN: 1178-7007 (Print) Linking ISSN: 11787007 NLM ISO Abbreviation: Diabetes Metab Syndr Obes Subsets: PubMed not MEDLINE

Baugh SD; Lexicon Pharmaceuticals, 350 Carter Road, Princeton, NJ 08540, United States. Electronic address: simondpbaugh@gmail.com.; Pabba PK; Lexicon Pharmaceuticals, 350 Carter Road, Princeton, NJ 08540, United States.; Barbosa J; Lexicon Pharmaceuticals, 350 Carter Road, Princeton, NJ 08540, United States.; Coulter E; Lexicon Pharmaceuticals, 8800 Technology Forest Place, The Woodlands, TX 7738, United States.; Desai U; Lexicon Pharmaceuticals, 8800 Technology Forest Place, The Woodlands, TX 7738, United States.; Gay JP; Lexicon Pharmaceuticals, 8800 Technology Forest Place, The Woodlands, TX 7738, United States.; Gopinathan S; Lexicon Pharmaceuticals, 8800 Technology Forest Place, The Woodlands, TX 7738, United States.; Han Q; Lexicon Pharmaceuticals, 350 Carter Road, Princeton, NJ 08540, United States.; Hari R; Lexicon Pharmaceuticals, 8800 Technology Forest Place, The Woodlands, TX 7738, United States.; Kimball SD; Lexicon Pharmaceuticals, 350 Carter Road, Princeton, NJ 08540, United States.; Nguyen HV; Lexicon Pharmaceuticals, 350 Carter Road, Princeton, NJ 08540, United States.; Ni CY; Lexicon Pharmaceuticals, 350 Carter Road, Princeton, NJ 08540, United States.; Powell DR; Lexicon Pharmaceuticals, 8800 Technology Forest Place, The Woodlands, TX 7738, United States.; Smith A; Lexicon Pharmaceuticals, 8800 Technology Forest Place, The Woodlands, TX 7738, United States.; Terranova KM; Lexicon Pharmaceuticals, 350 Carter Road, Princeton, NJ 08540, United States.; Wilson A; Lexicon Pharmaceuticals, 8800 Technology Forest Place, The Woodlands, TX 7738, United States.; Yu XC; Lexicon Pharmaceuticals, 8800 Technology Forest Place, The Woodlands, TX 7738, United States.; Lombardo VK; Lexicon Pharmaceuticals, 350 Carter Road, Princeton, NJ 08540, United States.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3405 (Electronic) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE